Showing results 5 to 7 of 7
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer Journal:Frontiers in Immunology | 2022 | 9 | ||
Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation Journal:Nature Communications | 2022 | 1 | ||
2022 | 3 |